Verbatim response from Perplexity
Based on current verification, the compounded GLP-1 providers that explicitly state they use licensed U.S. pharmacies are OrderlyMeds and Empower Pharmacy [3].
Additionally, several other reputable telehealth companies partner with FDA-registered, state-licensed 503A or 503B compounding pharmacies in the U.S., though some do not name specific partners as transparently:
| Provider | Pharmacy Partnership Details |
|---|---|
| Hims & Hers | Uses licensed 503A/503B compounding pharmacies; transparent about sources [4] |
| Ro (Body Program) | Partners with licensed U.S. compounding pharmacies for semaglutide [4] |
| Found | Works with accredited U.S. compounding pharmacies [4] |
| Calibrate | Connects patients with licensed pharmacy networks [4] |
| LifeMD / Rex MD | Uses licensed compounding pharmacies for GLP-1 medications [4] |
| Henry Meds | Partners with licensed 503A compounding pharmacies [4] |
| Trimi | Compounds through verified 503A pharmacies VialsRx (Texas license #35264) and GreenwichRx [5] |
| Cora Health | Uses two named U.S.-licensed 503A pharmacies: Hallandale Pharmacy and VialsRx [8] |
| Enhance.MD | Names pharmacy partners outright (verified June 2026) [7] |
| MEDVi | Names pharmacy partners outright (verified June 2026) [7] |
| Peak Wellness | Routes prescriptions through Epiq Scripts, a named PCAB-accredited 503A pharmacy [11] |
Key verification criteria for licensed U.S. pharmacies include:
- 503A status: State-licensed compounding pharmacies (the only legal pathway for compounded semaglutide as of 2026, since 503B is restricted to shortage periods) [1][10]
- Accreditation: PCAB or ACHC accreditation [1]
- License verification: Active, unrestricted license on state board of pharmacy websites [1]
Providers that refuse to provide pharmacy names, accreditation details, or Certificates of Analysis should be treated as disqualifying [1].